Leukemia Treatment Center in Tampa, FL
Moffitt Cancer Center offers comprehensive leukemia treatment in Tampa through our renowned Malignant Hematology Program. In one location, our patients have access to treatment and supportive care for all forms of acute and chronic leukemia. Our multispecialty team members are dedicated solely to the treatment of leukemia, giving them an unparalleled level of experience.
Leukemia treatment options at Moffitt
Every patient receiving leukemia treatment at Moffitt is offered an individualized treatment plan, which is developed based on his or her unique diagnosis and molecular profile. Because no two patients or cancers are alike, treatment varies, but may include any of the following therapies:
- Traditional chemotherapy – Chemo drugs travel through the bloodstream to destroy cancer cells and return blood counts to normal.
- Targeted therapies – Targeted therapy drugs work differently than traditional chemo in that they target specific parts of the cancer cells.
- Monoclonal antibody therapy – This form of immunotherapy uses antibodies to target parts of cancer cells in an effort to help the immune system destroy the cancer.
- Radiation therapy – High-energy radiation beams may be used to treat pain, shrink a tumor, address cancer that has spread or eliminate cancer cells prior to a bone marrow or blood stem cell transplant.
Blood and bone marrow transplant
A stem cell transplant is sometimes used to treat leukemia by replacing destroyed bone marrow. Because leukemia is often responsive to blood and bone marrow transplantation, Moffitt’s leukemia treatment team works closely with our Blood and Marrow Transplant and Cellular Immunotherapy Program to provide the best options for our patients.
As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt has received national recognition for our research efforts and robust clinical trials program. Our leukemia patients have unique opportunities to participate in clinical trials, which may include groundbreaking treatment options – such as immunotherapies and chemotherapy strategies – that are not yet widely available.